Works matching IS 11732563 AND DT 2021 AND VI 41 AND IP 9


Results: 9
    1

    Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience.

    Published in:
    Clinical Drug Investigation, 2021, v. 41, n. 9, p. 775, doi. 10.1007/s40261-021-01071-0
    By:
    • Milella, Giammarco;
    • Introna, Alessandro;
    • D'Errico, Eustachio;
    • Fraddosio, Angela;
    • Scaglione, Gaspare;
    • Morea, Antonella;
    • Ucci, Maria;
    • Ruggieri, Maddalena;
    • Mastrapasqua, Mariangela;
    • Megna, Marisa;
    • Puntillo, Filomena;
    • Simone, Isabella Laura
    Publication type:
    Article
    2
    3
    4
    6
    7

    FKB238: A Bevacizumab Biosimilar.

    Published in:
    Clinical Drug Investigation, 2021, v. 41, n. 9, p. 825, doi. 10.1007/s40261-021-01065-y
    By:
    • Syed, Yahiya Y.
    Publication type:
    Article
    8
    9